T. Rowe Price Associates, Inc. 13D and 13G filings for Repligen Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 10:26 am Purchase | 2025-12-31 | 13G | Repligen Corporation RGEN | T. Rowe Price Associates, Inc. | 4,599,860 8.200% | 1,170,313 (+34.12%) | Filing |
| 2025-09-08 1:35 pm Sale | 2025-08-31 | 13G | Repligen Corporation RGEN | T. Rowe Price Associates, Inc. | 3,429,547 6.100% | -3,706,539 (-51.94%) | Filing |
| 2025-02-14 09:44 am Purchase | 2024-12-31 | 13G | Repligen Corporation RGEN | T. Rowe Price Associates, Inc. | 7,136,086 12.700% | 743,841 (+11.64%) | Filing |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | Repligen Corporation RGEN | T. Rowe Price Associates, Inc. | 6,392,245 11.400% | 273,275 (+4.47%) | Filing |
| 2024-09-10 5:08 pm Purchase | 2024-08-31 | 13G | Repligen Corporation RGEN | T. Rowe Price Associates, Inc. | 6,118,970 10.900% | 2,106,119 (+52.48%) | Filing |
| 2024-02-14 10:02 am Sale | 2023-12-31 | 13G | Repligen Corporation RGEN | T. Rowe Price Associates, Inc. | 4,012,851 7.200% | -1,057,806 (-20.86%) | Filing |
| 2023-02-14 12:37 pm Purchase | 2022-12-31 | 13G | Repligen Corporation RGEN | T. Rowe Price Associates, Inc. | 5,070,657 9.100% | 2,028,002 (+66.65%) | Filing |
| 2022-02-14 2:34 pm Purchase | 2021-12-31 | 13G | Repligen Corporation RGEN | T. Rowe Price Associates, Inc. | 3,042,655 5.500% | 3,042,655 (New Position) | Filing |